[1] Affo S, Filliol A, Gores GJ, et al. Fibroblasts in liver cancer: functions and therapeutic translation [J]. Lancet Gastroenterol Hepatol, 2023, 8(8): 748-759. DOI: 10.1016/S2468-1253(23)00111-5.
[2] Lv K, Cao X, Du P, et al. Radiomics for the detection of microvascular invasion in hepatocellular carcinoma [J]. World J Gastroenterol, 2022, 28(20):2176-2183. DOI: 10.3748/wjg.v28.i20.2176.
[3] Feng J, Lu H, Ma W, et al. Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer [J]. Protein Cell, 2022, 13(11): 825-841. DOI: 10.1007/s13238-022-00906-6.
[4] 王志民,郭皓,王鹏立,等. Gd-EOB-DTPA增强MRI影像组学联合临床特征模型对恶性肝硬化结节的预测价值[J]. 中华实用诊断与治疗杂志,2024,38(3):268-274. DOI: 10.13507/j.issn.1674-3474.2024.03.011.
[5] Gumus M, Oommen KC, Squires JH. Contrast-enhanced ultrasound of the neonatal brain [J]. Pediatr Radiol, 2022, 52(4): 837-846. DOI: 10.1007/s00247-021-05157-x.
[6] 杨伟,罗倩,刘启榆,等. MSCT与MRI在肝硬化背景下小肝癌中的诊断价值[J]. 中国老年学杂志,2023,43(23):5670-5673. DOI:10.3969/j.issn.1005-9202.2023.23.011.
[7] Hu W, Chen H, Ma C, et al. Identification of indications for albumin administration in septic patients with liver cirrhosis [J]. Crit Care, 2023, 27(1):300. DOI: 10.1186/s13054-023-04587-3.
[8] 李新,刘明,阴肖玲,等. 超声引导下经皮肝脏组织穿刺活检在早期肝癌中的诊断价值[J]. 贵州医药,2023,47(3):443-444. DOI:10.3969/j.issn.1000-744X.2023.03.064.
[9] 王智,李长波,王斌杰,等. LI-RADS v2018对肝细胞癌高危人群肝脏病变的诊断效能:增强CT和Gd-EOB-MRI的对比研究[J]. 实用放射学杂志,2022,38(4):568-572. DOI: 10.3969/j.issn.1002-1671.2022.04.013.
[10] Sun Q, Wang A, Chang H. Contrast-enhanced ultrasound guidance improves the therapeutic efficacy of radiofrequency ablation in liver cancer patients [J]. Am J Transl Res, 2023, 15(6):3856-3863.
[11] Jiang ZP, Zeng KY, Huang JY, et al. Differentiating malignant and benign focal liver lesions in children using CEUS LI-RADS combined with serum alpha-fetoprotein [J]. World J Gastroenterol, 2022, 28(21): 2350-2360. DOI: 10.3748/wjg.v28.i21.2350.
[12] 梅文娟,李新,张昊月. 超声造影时间-强度曲线相关参数鉴别诊断肝细胞癌与转移性肝癌价值研究[J]. 实用肝脏病杂志,2024,27(3):430-433. DOI: 10.3969/j.issn.1672-5069. 2024.03.028.
[13] 范智慧,吴侠,黄玮,等. 肝癌患者超声造影参数与病理分级和甲胎蛋白的相关性研究[J]. 中国医学装备,2024,21(5):11-15. DOI:10.3969/j.issn.1672-8270.2024.05.002.
[14] 黄海涛,李舟跃,邬久燕,等. 超声造影及增强CT用于HBV感染相关性肝癌的诊断价值[J]. 中华医院感染学杂志,2024,34(5):707-711. DOI:10.11816/cn.ni.2024-231130.
[15] 张萍,周琼,曾智勇. 全氟丁烷微球超声造影对早期肝硬化合并结节状小细胞肝癌诊断效能评估[J]. 中国临床药理学杂志,2023,39(24):3580-3583. DOI: 10.13699/j.cnki. 1001-6821.2023.24.008.
[16] 郑丽丽,林艳艳,李军建,等. 超声造影诊断慢性肝病背景下最大径≤3 cm肝细胞肝癌的临床价值[J]. 临床超声医学杂志,2023,25(12):967-971. DOI: 10.3969/j.issn.1008-6978. 2023.12.008.
[17] 解玉文,张全禄,王萍萍. MRI与超声造影在肝细胞癌与血管瘤鉴别诊断中的应用[J]. 肝脏,2023,28(10):1195-1198. DOI:10.3969/j.issn.1008-1704.2023.10.015.
[18] 王开乐,金贤德,王甄,等. 多模态影像定量参数在肝硬化背景下小肝癌及增生结节的鉴别诊断价值[J]. 肝脏,2021,26(8):861-865. DOI:10.3969/j.issn.1008-1704.2021. 08.010.
[19] Campello CA, Castanha EB, Vilardo M, et al. Machine learning for malignant versus benign focal liver lesions on US and CEUS: a meta-analysis [J]. Abdom Radiol (NY), 2023, 48(10): 3114-3126. DOI: 10.1007/s00261-023- 03984-0.
[20] Peng YL, Liu LP, Zhang YJ, et al. Focal solitary necrotic nodules in fatty liver: characteristics on conventional and contrast-enhanced ultrasonography [J]. J Ultrasound, 2022, 25(4): 847-854. DOI: 10.1007/s40477-021- 00634-3.
[21] 丁云清,周莉,戈杨,等. 超声造影对肝硬化伴小肝癌的诊断价值及临床意义[J]. 广西医科大学学报,2023,40(8):1355-1361. DOI:10.16190/j.cnki.45-1211/r.2023.08.014.
[22] 张艳琴,刘戬,邓茂松. MSCT结合血清CCNA2、AFP检测在肝硬化结节与肝细胞肝癌鉴别诊断中的应用价值研究[J]. 中国CT和MRI杂志,2024,22(5):113-115. DOI: 10.3969/j.issn.1672-5131.2024.05.036.
[23] 宋文月,耿承军,江凯. T2WI序列图像与多期多排螺旋CT扫描对肝硬化患者结节和小肝癌的鉴别诊断价值[J]. 肝脏,2022,27(6):644-646,667. DOI: 10.3969/j.issn.1008-1704. 2022.06.010.
[24] 谢慧,王亮亮,江凯,等. 多层螺旋CT与高场强磁共振LAVA增强对乙型肝炎肝硬化背景小肝癌的诊断价值对比[J]. 肝脏,2022,27(8):895-897,907. DOI: 10.3969/j.issn.1008- 1704.2022.08.018.
[25] 谢卫东,王健,李扬. MRI多b值成像联合低剂量多层螺旋CT扫描对肝硬化再生结节与小肝癌结节的鉴别诊断价值[J]. 实用癌症杂志,2022,37(9):1503-1507. DOI: 10.3969/j.issn.1001-5930.2022.09.028.
|